Catecholamines can mediate stress-related effects on tumor progression

References

• Besedovsky HO, del Rey A. Physiological implications of the immune–neuro–endocrine network. In: Psychoneuroimmunology. Ader, R, Felten DL, Cohen N (Eds). Academic Press, CA, USA 589–608 (1991).
   Google Scholar
• Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol.5(10), 617–625 (2004).
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser J, Glaser R. Psychoneuroimmunology and cancer: fact or fiction? Eur. J. Cancer35, 1603–1607 (1999).
   PubMed Web of Science ®Google Scholar
• Riley V. Mouse mammary tumors: alteration of incidence as apparent function of stress. Science189(4201), 465–467 (1975).
   PubMed Web of Science ®Google Scholar
• Saul AN, Oberyszyn TM, Daugherty C et al. Chronic stress and susceptibility to skin cancer. J. Natl Cancer Inst.97(23), 1760–1767 (2005).
   PubMedGoogle Scholar
• Rabin BS. Stress, Immune Function, and Health: The Connection. Wiley-Liss, NY, USA (1999).
   Google Scholar
• Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol.24(8), 444–448 (2003).
   PubMed Web of Science ®Google Scholar
• Ader R. Psychoneuroimmunology. Ader R, Cohen N, Felten D (Eds). Elsevier/Academic Press, MA, USA (2007).
   Google Scholar
• Archer J, Hutchison I, Korszun A. Mood and malignancy: head and neck cancer and depression. J. Oral Pathol. Med.37(5), 255–270 (2008).
   PubMedGoogle Scholar
• Irwin MR. Depression and risk of cancer progression: an elusive link. J. Clin. Oncol.25(17), 2343–2344 (2007).
   PubMedGoogle Scholar
• Antoni MH, Lutgendorf SK, Cole SW et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat. Rev. Cancer6(3), 240–248 (2006).
   PubMed Web of Science ®Google Scholar
• Lewis CE, O’Brien RM, Barraclough J. Psychoimmunology of Cancer. Oxford University Press, Oxford, UK (2002).
   Google Scholar
• White V, English D, Coates H, Lagerlund M, Borland R, Giles G. Is cancer risk associated with anger control and negative affect? Findings from a prospective cohort study. Psychosom. Med.69(7), 667–674 (2007).
   PubMedGoogle Scholar
• DeNardo DG, Johansson M, Coussens LM. Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev.27(1), 11–18 (2008).
   PubMed Web of Science ®Google Scholar
• Hagemann T, Balkwill F, Lawrence T. Inflammation and cancer: a double-edged sword. Cancer Cell12(4), 300–301 (2007).
   PubMed Web of Science ®Google Scholar
• Apetoh L, Ghiringhelli F, Tesniere A et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med.13(9), 1050–1059 (2007).
   PubMed Web of Science ®Google Scholar
• Urosevic M, Maier T, Benninghoff B, Slade H, Burg G, Dummer R. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch. Dermatol.139(10), 1325–1332 (2003).
   PubMed Web of Science ®Google Scholar
• Urosevic M, Dummer R. Immunotherapy for nonmelanoma skin cancer. Cancer94, 477–485 (2002).
   PubMed Web of Science ®Google Scholar
• Szelenyi J, Vizi ES. The catecholamine–cytokine balance: interaction between the brain and the immune system. Ann. NY Acad. Sci.1113, 311–324 (2007).
   PubMed Web of Science ®Google Scholar
• Ortega E, Giraldo E, Hinchado MD, Martin L, Garcia JJ, De la Fuente M. Neuroimmunomodulation during exercise: role of catecholamines as ‘stress mediator’ and/or ‘danger signal’ for the innate immune response. Neuroimmunomodulation14(3–4), 206–212 (2007).
   PubMed Web of Science ®Google Scholar
• Ortega E, Marchena JM, Garcia JJ, Barriga C, Rodriguez AB. Norepinephrine as mediator in the stimulation of phagocytosis induced by moderate exercise. Eur. J. Appl. Physiol.93(5–6), 714–718 (2005).
   PubMed Web of Science ®Google Scholar
• Sanders VM, Kohm AP. Sympathetic nervous system interaction with the immune system. Int. Rev. Neurobiol.52, 17–41 (2002).
   PubMed Web of Science ®Google Scholar
• Elenkov IJ, Chrousos GP. Stress system – organization, physiology and immunoregulation. Neuroimmunomodulation13(5–6), 257–267 (2006).
   PubMed Web of Science ®Google Scholar
• Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve – an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev.52(4), 595–638 (2000).
   PubMed Web of Science ®Google Scholar
• Bierhaus A, Wolf J, Andrassy M et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl Acad. Sci. USA100(4), 1920–1925 (2003).
   PubMed Web of Science ®Google Scholar
• Sloan EK, Capitanio JP, Cole SW. Stress-induced remodeling of lymphoid innervation. Brain Behav. Immun.22(1), 15–21 (2008).
   PubMedGoogle Scholar
• Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987–2007). Brain Behav. Immun.21(6), 736–745 (2007).
   PubMed Web of Science ®Google Scholar
• Garcia JJ, del Carmen Saez M, De la Fuente M, Ortega E. Noradrenaline and its end metabolite 3-methoxy-4-hydroxyphenylglycol inhibit lymphocyte chemotaxis: role of α- and β-adrenoreceptors. Mol. Cell. Biochem.254(1–2), 305–309 (2003).
   PubMedGoogle Scholar
• Straub RH, Mayer M, Kreutz M, Leeb S, Scholmerich J, Falk W. Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J. Leuk. Biol.67(4), 553–558 (2000).
   PubMedGoogle Scholar
• Ortega E, Garcia JJ, De la Fuente M. Modulation of adherence and chemotaxis of macrophages by norepinephrine. Influence of ageing. Mol. Cell. Biochem.203(1–2), 113–117 (2000).
   PubMedGoogle Scholar
• Entschladen F, Drell TL, Lang K, Joseph J, Zaenker KS. Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol.5(4), 254–258 (2004).
   PubMed Web of Science ®Google Scholar
• Schuller HM, Porter B, Riechert A. β-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters. J. Cancer Res. Clin. Oncol.126(11), 624–630 (2000).
   PubMed Web of Science ®Google Scholar
• Ito A, Satoh M, Ohyama C et al. Adrenal metastasis from renal cell carcinoma: significance of adrenalectomy. Int. J. Urol.9(3), 125–128 (2002).
   PubMed Web of Science ®Google Scholar
• Siren J, Tervahartiala P, Sivula A, Haapiainen R. Natural course of adrenal incidentalomas: seven-year follow-up study. World J. Surg.24(5), 579–582 (2000).
   PubMed Web of Science ®Google Scholar
• Moriya T, Manabe T, Yamashita K, Arita S. Lung cancer metastasis to adrenocortical adenomas. A chance occurrence or a predilected phenomenon? Arch. Pathol. Lab. Med.112(3), 286–289 (1988).
   PubMedGoogle Scholar
• Schouten LJ, Rutten J, Huveneers HAM, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer94(10), 2698–2705 (2002).
   PubMed Web of Science ®Google Scholar
• Drell TL, Joseph J, Lang K, Niggemann B, Zaenker KS, Entschladen F. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res. Treat.80(1), 63–70 (2003).
   PubMed Web of Science ®Google Scholar
• Masur K, Niggemann B, Zanker KS, Entschladen F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by β-blockers. Cancer Res.61(7), 2866–2869 (2001).
   PubMed Web of Science ®Google Scholar
• Palm D, Lang K, Niggemann B et al. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by β-blockers. Int. J. Cancer118(11), 2744–2749 (2006).
   PubMed Web of Science ®Google Scholar
• Sood AK, Bhatty R, Kamat AA et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin. Cancer Res.12(2), 369–375 (2006).
   PubMed Web of Science ®Google Scholar
• Yang EV, Sood AK, Chen M et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res.66(21), 10357–10364 (2006).
   PubMed Web of Science ®Google Scholar
• Lutgendorf SK, Cole S, Costanzo E et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res.9(12), 4514–4521 (2003).
   PubMed Web of Science ®Google Scholar
• Lutgendorf SK, Johnsen EL, Cooper B et al. Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer95(4), 808–815 (2002).
   PubMed Web of Science ®Google Scholar
• Yang EV, Donovan EL, Benson DM, Glaser R. VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav. Immun.22(3), 318–323 (2008).
   PubMed Web of Science ®Google Scholar
• Thaker PH, Han LY, Kamat AA et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med.12(8), 939 (2006).
   PubMed Web of Science ®Google Scholar
• Landen CN Jr, Lin YG, Armaiz Pena GN et al. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res.67(21), 10389–10396 (2007).
   PubMed Web of Science ®Google Scholar
• Nilsson MB, Armaiz-Pena G, Takahashi R et al. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J. Biol. Chem.282(41), 29919–29926 (2007).
   PubMed Web of Science ®Google Scholar
• Perron L, Bairati I, Harel F, Meyer F. Antihypertensive drug use and the risk of prostate cancer (Canada). Cancer Causes Control15(6), 535–541 (2004).
   PubMed Web of Science ®Google Scholar
• Algazi M, Plu-Bureau G, Flahault A, Dondon MG, Le MG. Is β-blocker treatment associated with a decrease in the risk of cancer. Lett. Drug Des. Discov.3, 653–661 (2006).
   Web of Science ®Google Scholar